Newbridge Financial Services Group’s Precision BioSciences DTIL Stock Holding History

Newbridge Financial Services Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.8K	Hold	1,600	–	–	﹤0.01%	817
2025 Q4	$6.66K	Hold	1,600	–	–	﹤0.01%	854
2025 Q3	$8.83K	Hold	1,600	–	–	﹤0.01%	923
2025 Q2	$6.72K	Hold	1,600	–	–	﹤0.01%	976
2025 Q1	$7.63K	Hold	1,600	–	–	﹤0.01%	729
2024 Q4	$6.1K	Buy	+1,600	New	+$11.7K	﹤0.01%	834
2021 Q4	–	Sell	-915	Closed	-$256K	–	1441
2021 Q3	$317K	Sell	915 -25	-3%	-$8.47K	0.2%	115
2021 Q2	$353K	Sell	940 -395	-30%	-$119K	0.22%	108
2021 Q1	$415K	Buy	1,335 +1,310	+5,240%	+$459K	0.31%	76
2020 Q4	$6K	Buy	+25	New	+$6.13K	﹤0.01%	813

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Newbridge Financial Services Group's DTIL Position: Q1 2026 in Review

Newbridge Financial Services Group held its Precision BioSciences (DTIL) position steady in Q1 2026 at 1,600 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #817.

Newbridge Financial Services Group first reported a position in DTIL in Q4 2020 and has held it in 10 quarters since. The position peaked at $415K in Q1 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Newbridge Financial Services Group held 1,600 shares of Precision BioSciences worth $8.8K as of Q1 2026.
Newbridge Financial Services Group left its Precision BioSciences share count unchanged in Q1 2026.
Precision BioSciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #817 holding.
Newbridge Financial Services Group first reported a position in Precision BioSciences in Q4 2020 and has held it in 10 quarters since.
Newbridge Financial Services Group's Precision BioSciences position peaked at $415K in Q1 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.